Spotlight: Intec enrolls patients in PhIII trial

An MIT team has invented a device that makes a variety of drugs "on demand." "Think of this as the emergency backup for pharmaceutical manufacturing," MIT chemical engineering professor Allan Myerson said in a news release. "The purpose is not to replace traditional manufacturing; it's to provide an alternative for these special situations." More

> Intec Pharma enrolled its first patient in the Phase III trial of its drug delivering Accordion Pill for the treatment of Parkinson's Disease. More

> Sweden's Moberg Pharma has divested Jointflex, Fergon and Vanquish brands to Strides Pharma for $10.4 million. More